TL;DR
This study introduces a novel application of photoacoustic microscopy (PAM) to quantitatively assess the impact of carfilzomib, a multiple myeloma drug, on peripheral blood vessels in vivo. The findings demonstrate that carfilzomib significantly alters vascular dynamics, suggesting PAM's potential as a tool for predicting cardiovascular side effects associated with this drug.
What Problem Does This Paper Address?
Carfilzomib is a crucial treatment for multiple myeloma, but it's known to cause cardiovascular adverse events, including hypertension and heart failure. While these events are a concern, the precise mechanisms by which carfilzomib affects the peripheral vasculature, particularly at the microvascular level, remain poorly understood. Existing imaging techniques like CT and MRI have limitations in resolution, radiation exposure, and cost. Ultrasound Doppler is limited to microvasculature visualization. Optical methods like confocal microscopy and multiphoton microscopy have shallow penetration depths. This paper aims to address this gap by employing photoacoustic microscopy (PAM), a technique that combines optical contrast with ultrasonic resolution and deeper penetration, to quantitatively monitor changes in peripheral vasculature induced by carfilzomib.
Methods
The researchers utilized an Optical-Resolution Photoacoustic Microscopy (OR-PAM) system to image the peripheral vasculature of mouse ears. This system employs a 532 nm pulsed laser to generate photoacoustic waves upon absorption by blood, which are then detected by an ultrasonic transducer. The OR-PAM system is capable of acquiring high-resolution 3D images.
The core of their methodology involved:
- In Vivo Imaging: Mouse ears were imaged for 10 hours before and after the intravenous injection of carfilzomib, bortezomib (another proteasome inhibitor), and PBS (as a control).
- Image Processing and Segmentation: A multi-scale Hessian filter was used for image segmentation to delineate blood vessels from the background. Adaptive thresholding and morphological operations were applied to create binary and skeleton maps of the vasculature.
- Quantitative Parameter Extraction: Five key quantitative parameters were extracted from the OR-PAM images:
- PA Signal: Reflects the intensity of absorbed photons by blood.
- Diameter: Represents the size of the blood vessels.
- Density: Indicates the proportion of the area occupied by vessels.
- Length Fraction: Measures the total length of vessels relative to the area.
- Fractal Dimension: Quantifies the complexity and tortuosity of the vascular network.
- Comparative Analysis: The quantitative data from carfilzomib, bortezomib, and PBS groups were compared to assess the specific effects of each substance.
Datasets
Not discussed in the paper. The study relies on in vivo imaging data collected from experimental subjects (mice).
Key Insights and Ideas
- PAM as a Sensitive Tool for Drug Effects: The study demonstrates that OR-PAM is highly effective in visualizing and quantitatively assessing the dynamic changes in peripheral vasculature induced by pharmacological agents.
- Carfilzomib's Pronounced Vascular Impact: Carfilzomib induced significant, rapid, and widespread changes in all measured vascular parameters, far exceeding the effects of bortezomib or PBS. This suggests a strong and direct impact on the microvasculature.
- Timing of Carfilzomib's Effect: The peak effect of carfilzomib on vascular dynamics was observed within the first 30 minutes post-injection, characterized by increased PA signal, vessel dilation, and microvascular proliferation.
- Differential Effects of Proteasome Inhibitors: While both carfilzomib and bortezomib are proteasome inhibitors, carfilzomib showed a substantially greater impact on peripheral vasculature, highlighting differences in their pharmacodynamics and potential for side effects.
- Predictive Potential of PAM: The quantitative changes observed in vascular parameters following carfilzomib administration suggest that PAM could potentially be used as a predictive tool for identifying patients at risk of carfilzomib-induced cardiovascular events.
Key Results
- Morphological Changes: Carfilzomib injection led to the appearance of bleeding spots and the emergence of new microvasculatures within 10-30 minutes. These changes gradually subsided over 10 hours, with the vasculature returning to a near-baseline state.
- Quantitative Parameter Increases: Following carfilzomib administration, all five quantitative vascular parameters (PA signal, diameter, density, length fraction, and fractal dimension) showed significant increases, with some parameters rising by up to 50% within the first 30 minutes.
- Bortezomib and PBS Effects: Bortezomib and PBS injections resulted in minimal changes to the vascular parameters, with variations generally staying below 20% and showing no consistent trend.
- Magnitude of Carfilzomib Effect: The average PA signal with carfilzomib was approximately eight times higher than with bortezomib and 5.5 times higher than with PBS. Similarly, other parameters showed significantly higher increases with carfilzomib.
- Capillary Impact: The study suggests that carfilzomib has a stronger impact on capillaries than on larger blood vessels, as indicated by the significant changes in length fraction and fractal dimension.
Limitations and Future Work
- Penetration Depth: The current OR-PAM system has a limited penetration depth of approximately 1 mm, which hinders its direct clinical application for deeper tissues.
- Future Work: The authors suggest developing handheld probes and utilizing near-infrared lasers for deeper imaging in human applications.
- Functional Information: The use of a single laser wavelength (532 nm) limits the ability to differentiate between oxygenated (HbO2) and deoxygenated (HbR) hemoglobin, thus restricting the assessment of functional parameters like oxygen saturation (SO2) and cerebral metabolic rate of oxygen (CMRO2).
- Future Work: Combining multiple laser wavelengths would enable direct measurement of hemoglobin concentrations and provide more comprehensive functional information about the vasculature.
- Pilot Study Nature: The study is described as a pilot study, implying a need for larger-scale investigations to confirm these findings and establish robust clinical correlations.
Summary updated